2021 Incentive Grant Recipient: Ariel McDuffie, PharmD
Residents and their Preceptors
Project Proposal: Evaluation of Pharmacist-Led Telehealth Smoking Cessation Services in a Primary Care Setting
Ariel McDuffie, PharmD, RPh, currently serves as the PGY2 Ambulatory Care Resident at The Ohio State University College of Pharmacy and PrimaryOne Health in Columbus, Ohio.
Nearly 70% of adults who smoke say they want to quit, and more than 50% try each year. The impact of this study will help in identifying pharmacist as key health care providers that can assist in dedicating the time to counsel patients on the importance of quitting smoking and assisting with motivational interviewing and medication management.
As a part of the primary care team, pharmacists at P1H work with patients and providers to design therapeutic treatment plans for the management of many chronic disease states, including smoking cessation. P1H clinical pharmacists have been providing smoking cessation services since 2011 and manage some patients under collaborative practice agreements (CPA). The motivation behind this project proposal is that it will assist in allowing us to determine the impact of pharmacist-led services which could ultimately be used to support payment for pharmacist services and expansion of pharmacists’ prescriptive authority for tobacco use disorder.
What I am most excited about my project and receiving an Incentive Grant is the opportunity to illustrate the pharmacist’s value in managing chronic conditions like smoking cessation. My hope is that this study’s impact will show that pharmacist are essential in the primary care setting and have the time and skills necessary to provide in-depth counseling, motivational interviewing, and medication management.